Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 2416 AL 2430

Neurodegenerative Disease Associated Pathways in the Brains of Triple Transgenic Alzheimer's Model Mice Are Reversed Following Two Weeks of Peripheral Administration of Fasudil

Killick R, Elliott C, Ribe E, Broadstock M, Ballard C, Aarsland D, Williams G.

Int J Mol Sci. 2023 Jul 7;24(13):11219. doi: 10.3390/ijms241311219.

Gut Microbiota and Its Repercussion in Parkinson's Disease: A Systematic Review in Occidental Patients

Proano AC, Viteri JA, Orozco EN, Calle MA, Costa SC, Reyes DV, German-Montenegro M, Moncayo DF, Tobar AC, Moncayo JA.

Neurol Int. 2023 Jun 13;15(2):750-763. doi: 10.3390/neurolint15020047.

Association Between Bipolar Disorder and Parkinson's Disease

Geelhand de Merxem R, Launay S, Hanak C.

Psychiatr Danub. 2023 Oct;35(Suppl 2):66-71.

Recent trends in wearable device used to detect freezing of gait and falls in people with Parkinson's disease: A systematic review

Huang T, Li M, Huang J.

Front Aging Neurosci. 2023 Feb 15;15:1119956. doi: 10.3389/fnagi.2023.1119956. eCollection 2023.

Inflammatory bowel disease and risk of Parkinson's disease: evidence from a meta-analysis of 14 studies involving more than 13.4 million individuals

Li HX, Zhang C, Zhang K, Liu YZ, Peng XX, Zong Q.

Front Med (Lausanne). 2023 Apr 20;10:1137366. doi: 10.3389/fmed.2023.1137366. eCollection 2023.

α-Synuclein Strains and Their Relevance to Parkinson's Disease, Multiple System Atrophy, and Dementia with Lewy Bodies

Graves NJ, Gambin Y, Sierecki E.

Int J Mol Sci. 2023 Jul 28;24(15):12134. doi: 10.3390/ijms241512134.

The Parkinson's disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons

Jones-Tabah J, He K, Senkevich K, Karpilovsky N, Deyab G, Cousineau Y, Nikanorova D, Goldsmith T, Del Cid Pellitero E, Chen CX, Luo W, You Z, Abdian N, Pietrantonio I, Goiran T, Ahmad J, Ruskey JA, Asayesh F, Spiegelman D, Waters C, Monchi O, Dauvilliers Y, Dupré N, Miliukhina I, Timofeeva A, Emelyanov A, Pchelina S, Greenbaum L, Hassin-Baer S, Alcalay RN, Milnerwood A, Durcan TM, Gan-Or Z, Fon EA.

bioRxiv [Preprint]. 2023 Nov 15:2023.11.11.566693. doi: 10.1101/2023.11.11.566693.

Brain MRI Biomarkers in Isolated Rapid Eye Movement Sleep Behavior Disorder: Where Are We? A Systematic Review

Grimaldi S, Guye M, Bianciardi M, Eusebio A.

Brain Sci. 2023 Sep 30;13(10):1398. doi: 10.3390/brainsci13101398.

Nuclease-dead S. aureus Cas9 downregulates alpha-synuclein and reduces mtDNA damage and oxidative stress levels in patient-derived stem cell model of Parkinson's disease

Sastre D, Zafar F, Torres CAM, Piper D, Kirik D, Sanders LH, Qi S, Schüle B.

bioRxiv [Preprint]. 2023 Jan 24:2023.01.24.525105. doi: 10.1101/2023.01.24.525105.

Correction: Optical coherence tomography angiography measurements in Parkinson's disease: a systematic review and meta-analysis

Salehi MA, Rezagholi F, Mohammadi S, Zakavi SS, Jahanshahi A, Gouravani M, Yazdanpanah G, Seddon I, Jabbehdari S, Singh RP.

Eye (Lond). 2023 Oct;37(15):3298. doi: 10.1038/s41433-023-02691-w.

Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study

Rizig M, Bandres-Ciga S, Makarious MB, Ojo OO, Crea PW, Abiodun OV, Levine KS, Abubakar SA, Achoru CO, Vitale D, Adeniji OA, Agabi OP, Koretsky MJ, Agulanna U, Hall DA, Akinyemi RO, Xie T, Ali MW, Shamim EA, Ani-Osheku I, Padmanaban M, Arigbodi OM, Standaert DG, Bello AH, Dean MN, Erameh CO, Elsayed I, Farombi TH, Okunoye O, Fawale MB, Billingsley KJ, Imarhiagbe FA, Jerez PA, Iwuozo EU, Baker B, Komolafe MA, Malik L, Nwani PO, Daida K, Nwazor EO, Miano-Burkhardt A, Nyandaiti YW, Fang ZH, Obiabo YO, Kluss JH, Odeniyi OA, Hernandez DG, Odiase FE, Tayebi N, Ojini FI, Sidranksy E, Onwuegbuzie GA, D'Souza AM, Osaigbovo GO, Berhe B, Osemwegie N, Reed X, Oshinaike OO, Leonard HL, Otubogun FM, Alvarado CX, Oyakhire SI, Ozomma SI, Samuel SC, Taiwo FT, Wahab KW, Zubair YA, Iwaki H, Kim JJ, Morris HR, Hardy J, Nalls MA, Heilbron K, Norcliffe-Kaufmann L; Nigeria Parkinson Disease Research Network; International Parkinson's Disease Genomics Consortium Africa; Black and African American Connections to Parkinson's Disease Study Group; 23andMe Research Team; Blauwendraat C, Houlden H, Singleton A, Okubadejo NU; Global Parkinson's Genetics Program.

Lancet Neurol. 2023 Nov;22(11):1015-1025. doi: 10.1016/S1474-4422(23)00283-1. Epub 2023 Aug 23.

Multicohort cross-sectional study of cognitive and behavioural digital biomarkers in neurodegeneration: the Living Lab Study protocol

Crook-Rumsey M, Daniels SJC, Abulikemu S, Lai H, Rapeaux A, Hadjipanayi C, Soreq E, Li LM, Bashford J, Jeyasingh-Jacob J, Gruia DC, Lambert D, Weil R, Hampshire A, Sharp DJ, Haar S.

BMJ Open. 2023 Aug 3;13(8):e072094. doi: 10.1136/bmjopen-2023-072094.

Unveiling the Hidden Challenges: Non-Motor Disorders in Parkinson's Disease

Nieto-Escamez F, Obrero-Gaitán E, García-López H, Cortés-Pérez I.

Brain Sci. 2023 Dec 12;13(12):1710. doi: 10.3390/brainsci13121710.

Complement C1q-dependent engulfment of alpha-synuclein induces ENS-resident macrophage exhaustion and accelerates Parkinson's-like gut pathology

Mackie PM, Koshy J, Bhogade M, Hammoor T, Hachmeister W, Lloyd GM, Paterno G, Bolen M, Tansey MG, Giasson BI, Khoshbouei H.

bioRxiv [Preprint]. 2023 Oct 28:2023.10.24.563832. doi: 10.1101/2023.10.24.563832.

Human brain single nucleus cell type enrichments in neurodegenerative diseases

Alvarado CX, Weller CA, Johnson N, Leonard HL, Singleton AB, Reed X, Blauewendraat C, Nalls M.

medRxiv [Preprint]. 2023 Jul 1:2023.06.30.23292084. doi: 10.1101/2023.06.30.23292084.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias